-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2017.pdf
January 01, 2017 - patients younger than 65 include people who are disabled or who have been diagnosed
with end-stage renal … 109: Acute cerebrovascular
disease
232,510 14.73 15.23 3.4
157: Acute and unspecified
renal … 308 22.73 23.38 2.9
32: Cancer of bladder 14,780 22.18 23.03 3.8
33: Cancer of kidney and
renal … 2.8
155: Other gastrointestinal
disorders 73,673 20.39 20.92 2.6
156: Nephritis; nephrosis;
renal … sclerosis 1,488 25.00 25.54 2.2
157: Acute and unspecified
renal failure 228,134 22.04 22.60
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2016.pdf
January 01, 2016 - patients younger than 65 include people who are disabled or who have been diagnosed
with end-stage renal … 109: Acute cerebrovascular
disease
232,510 14.73 15.23 3.4
157: Acute and unspecified
renal … 308 22.73 23.38 2.9
32: Cancer of bladder 14,780 22.18 23.03 3.8
33: Cancer of kidney and
renal … 2.8
155: Other gastrointestinal
disorders 73,673 20.39 20.92 2.6
156: Nephritis; nephrosis;
renal … sclerosis 1,488 25.00 25.54 2.2
157: Acute and unspecified
renal failure 228,134 22.04 22.60
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - Depending on the success of the development pathway for some of the interventions, such as
catheter-based renal … Lymphomas
Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders
Catheter-Based Renal … Catheter-Based Renal
Denervation (Symplicity
System) for Treatment-
Resistant Hypertension
The Symplicity … Assuming a 50% decrease in the need for antihypertensive
medications after catheter-based renal denervation … Cell Carcinoma Pharmaceutical $180,000,000 $140,000,000
Cardiovascular
Disease
Catheter-Based Renal
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-section-2.pdf
January 01, 2020 - GENITOURINARY SYSTEM (580
629)
Nephritis, Nephrotic Syndrome,
And Nephrosis (580-589)
5856 End stage renal … Tracheostomy status
V441 Gastrostomy status
V4452 Appendico-vesicos status
V4512 Noncmplnt w renal
-
hcup-us.ahrq.gov/reports/race/50_state_r_e_rpt.jsp
July 01, 2016 - System, Disease Surveillance, Asthma Call-Back Survey, National Aging Program Information System, US Renal … Nutrition Surveillance System, Disease Surveillance, National Aging Program Information System, US Renal
-
effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research
-
psnet.ahrq.gov/sites/default/files/2020-05/final_may-spotlight-fatal_pca_slides_05.01.2020_cme_review-revised.pdf
January 01, 2020 - risk-related genetic
polymorphism
• Smoker
• Confirmed or suspected obstructive
sleep apnea (OSA)
• Renal
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/vae/monitoring-vae-slides.pptx
January 01, 2017 - assessment method of antimicrobial therapy without the need for specific information, such as—
Drug dosing
Renal
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/early-mobility-icu-slides.pptx
January 01, 2017 - (0.44-0.73)
Deep vein thrombosis 10.9 6.7 0.64 (0.48-0.85)
Psychiatric 3.4 1.7 0.60 (0.35-1.04)
Renal
-
meps.ahrq.gov/data_files/publications/st508/stat508.shtml
January 01, 2018 - age 65 and older, persons receiving Social Security disability payments, and persons with end-stage renal
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/sepsis-slides.pptx
November 01, 2019 - resistance to beta-lactams (< 10%)
No difference in shock duration or 14-day mortality
Association with renal
-
digital.ahrq.gov/sites/default/files/docs/publication/u18hs016970-bates-final-report-2012.pdf
January 01, 2012 - participated in the survey to identify ADEs,
medication allergies, comorbidities, specific lab results (e.g., renal … We measured rates of testing for lipid levels and renal function, levels of blood pressure and lipid … Medical Error: A 60 year old Man with Delayed Care for a Renal Mass: Clinical Crossroads,
Journal of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - can result in adverse outcomes,
commonly minimal trauma atypical fractures, esophageal irritation, renal … adverse effects from
bisphosphonates include minimal trauma atypical fractures, esophageal irritation, renal … smokers or past smokers within
the previous 15 years; Women
with current diagnosis or a history
of renal … breath or chest
pain
Any medical condition that
might affect BMD (e.g., bone
cancer, end-stage renal
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/medicaidreadmitguide/medread-tools.pdf
July 28, 2016 - Heart Failure 120 500 24% 5%
Sepsis 100 500 20% 4%
Psychosis 80 400 20% 3%
COPD 70 300 23% 3%
Renal … 2550 22%
Heart Failure 200 1300 15% 8%
COPD 30 300 10% 1%
Intracranial hemorrhage 25 50 50% 1%
Renal … 40 25% 0%
Medicaid Cellulitis 10 100 10% 0%
COPD with MCC 5 30 17% 0%
Chest pain 5 35 14% 0%
Renal … Medicaid adults
Behavioral health
Social support needs
High‐risk diagnoses based on your data (sepsis, renal
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
December 10, 2019 - Control:
Serious cardiac event: 9 (8.3)
Serious pulmonary event: 1 (0.9)
Serious renal … Intervention:
Serious cardiac event: 17 (5.3)
Serious pulmonary event: 4 (1.2)
Serious renal … Control:
Serious cardiac event: 9 (8.3)
Serious pulmonary event: 1 (0.9)
Serious renal … NSQIP
Overbey et al, 70
2017
NR
4471
31 (0.7)
150 (3.4)
304 (6.8)
NR
NR
Acute renal
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - PROCEDURES W CC 12,935 0.04%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 1,450 0.00%
682: RENAL … FAILURE W MCC 219,600 0.61%
683: RENAL FAILURE W CC 303,280 0.85%
684: RENAL FAILURE W/O CC/MCC 50,525 … 0.14%
685: ADMIT FOR RENAL DIALYSIS 140 0.00%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 4,020 0.01%
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
January 01, 2016 - 2018 34
Weighted Frequency Distribution for DRG_NOPOA
DRG_NoPOA Frequency
Percent
of Total
682: RENAL … FAILURE W MCC 234,220 0.66%
683: RENAL FAILURE W CC 311,525 0.87%
684: RENAL FAILURE W/O CC/MCC 58,530 … 0.16%
685: ADMIT FOR RENAL DIALYSIS 240 0.00%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 3,745 0.01%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
January 01, 2016 - PROCEDURES W CC 6,527 0.04%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 973 0.01%
682: RENAL … FAILURE W MCC 116,452 0.68%
683: RENAL FAILURE W CC 160,581 0.93%
684: RENAL FAILURE W/O CC/MCC 31,623 … 0.18%
685: ADMIT FOR RENAL DIALYSIS 120 0.00%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 1,893 0.01%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - PROCEDURES W CC 10,006 0.06%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 897 0.01%
682: RENAL … FAILURE W MCC 117,858 0.67%
683: RENAL FAILURE W CC 166,008 0.94%
684: RENAL FAILURE W/O CC/MCC 26,897 … 0.15%
685: ADMIT FOR RENAL DIALYSIS 67 0.00%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 2,339 0.01%
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
January 01, 2016 - TRACT PROCEDURES W CC 120 0.00%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 50 0.00%
682: RENAL … FAILURE W MCC 1,067 0.03%
683: RENAL FAILURE W CC 2,322 0.07%
684: RENAL FAILURE W/O CC/MCC 775 0.02% … 685: ADMIT FOR RENAL DIALYSIS <= 10 *.**%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 33 0.00%
687